FIELD: chemistry.
SUBSTANCE: invention relates to 2,8-bis-(5-methylisoxazol-3-yl or 1,5-dimethyl-3-oxo-2-phenyl-1,2-dihydro-3H-pyrazol-4-yl)-2,3 ,8,9,12c,12d-hexahydro-1H,7H-5,11-dioxa-2,3a,4,6,6b,8,9a,10,12,12b-decaazadicyclopenta[e,l]pyrenes of general formula (one):
Also described is a method for obtaining the above compound, which consists in the interaction of hetarylamine of the general formula Het-NH2 (where Het = 5-methylisoxazol-3-yl or 1,5-dimethyl-3-oxo-2-phenyl-1,2-dihydro-3H -pyrazol-4-yl) with formaldehyde and 1,4,5,8-tetraazadifurazano[3,4-c][3,4-h]decalin in the presence of a conc. HCl at the molar ratio of hetarylamine : formaldehyde : 1,4,5,8-tetraazadifurazano[3,4-c][3,4-h]decalin : HCl=2:4:1:(0.03-0.07) in CH3OH-DMSO at a temperature of 20°C and atmospheric pressure for 2.5-3.5 hours.
EFFECT: resulting heterocycles exhibit cytotoxic activity and can be used as candidate compounds for the development of drugs with antitumor activity and antiproliferative activity.
3 cl, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING 2,8-BIS-(4-HYDROXYPHENYL, 4-CARBOXYPHENYL)-2,3,8,9,12C,12D-HEXAHYDRO-1H,7H-5,11-DIOXA-2,3A,4,6,6B,8,9A,10,12,12B-DECAAZADICYCLOPENTA[E,L]PYRENES | 2019 |
|
RU2736378C1 |
METHOD OF PRODUCING 2,8-BIS-CYCLOALKYL-2,3,8,9,12C,12D-HEXAHYDRO-1H,7H-5,11-DIOXA-2,3A,4,6,6B,8,9A,10,12,12B-DECA-CYCLOCAPENTA[E,L]PYRENES | 2018 |
|
RU2696778C1 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
DERIVATIVES OF INDOLE-3-YL | 2001 |
|
RU2257380C2 |
METHYL 4-ARYL-1-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)-2,3-DIOXO-2,3,5,10 -TETRAHYDROBENZO[b]PYRROLO[2,3-e][1,4]DIAZEPINE-10a(1H)-CARBOXYLATES EXHIBITING ANALGESIC ACTIVITY, AND METHOD OF THEIR PREPARATION | 2022 |
|
RU2811413C1 |
MACROCYCLIC COMPOUNDS AS STING AGONISTS AND METHODS USING THEM AND WAYS OF USE THEREOF | 2020 |
|
RU2825271C2 |
ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
NOVEL COMPOUNDS OF SUBSTITUTED N-(3-FLUOROPROPYL)PYRROLIDINE, METHODS FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATION THEREOF | 2017 |
|
RU2742278C2 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
Authors
Dates
2022-12-08—Published
2021-07-30—Filed